QCM
TBPH icon

Quantinno Capital Management’s Theravance Biopharma TBPH Stock Holding History

Quantinno Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
18,038
+4,463
+33% +$79K ﹤0.01% 3045
2025
Q4 		$254K Buy
13,575
+1,352
+11% +$22.4K ﹤0.01% 2932
2025
Q3 		$178K Buy
+12,223
New +$154K ﹤0.01% 2793

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantinno Capital Management's TBPH Position: Q1 2026 in Review

Quantinno Capital Management increased its Theravance Biopharma (TBPH) stake by 33% in Q1 2026, buying an estimated $79K and bringing the position to 18,038 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #3045.

Quantinno Capital Management first reported a position in TBPH in Q3 2025 and has held it in 3 quarters since. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Quantinno Capital Management held 18,038 shares of Theravance Biopharma worth $293K as of Q1 2026.
  • Quantinno Capital Management bought 4,463 Theravance Biopharma shares in Q1 2026, an estimated $79K.
  • Theravance Biopharma made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3045 holding.
  • Quantinno Capital Management first reported a position in Theravance Biopharma in Q3 2025 and has held it in 3 quarters since.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.